Anticholinergic drugs and their effects on delirium and mortality in the elderly [0.03%]
抗胆碱能药物与老年人谵妄及死亡率的关系
M J Luukkanen,J Uusvaara,J V Laurila et al.
M J Luukkanen et al.
Aim: To investigate the use of drugs with anticholinergic properties (DAPs) and their associations with delirium and mortality among elderly patients with comorbidities. ...
Screening for new biomarkers for subcortical vascular dementia and Alzheimer's disease [0.03%]
用于筛选新的亚皮层血管性痴呆和阿尔茨海默病生物标志物的研究
Annika Ohrfelt,Ulf Andreasson,Adam Simon et al.
Annika Ohrfelt et al.
Background: Novel biomarkers are important for identifying as well as differentiating subcortical vascular dementia (SVD) and Alzheimer's disease (AD) at an early stage in the disease process. ...
Different characteristics of cognitive impairment in elderly schizophrenia and Alzheimer's disease in the mild cognitive impairment stage [0.03%]
轻度认知障碍期老年精神分裂症和阿尔茨海默病患者认知损害特点不同
Hiroaki Kazui,Tetsuhiko Yoshida,Masahiko Takaya et al.
Hiroaki Kazui et al.
We compared indices of the revised version of the Wechsler Memory Scale (WMS-R) and scaled scores of the five subtests of the revised version of the Wechsler Adult Intelligence Scale (WAIS-R) in 30 elderly schizophrenia (ES) patients and 25...
An open-label, multicenter observational study for patients with Alzheimer's disease treated with memantine in the clinical practice [0.03%]
开放性多中心老年痴呆马利刚临床用药观察研究
S S Stamouli,M Tzanakaki,S Giatas et al.
S S Stamouli et al.
Background/aims: In this post-marketing observational study, the safety and effectiveness of memantine were evaluated in patients with Alzheimer's disease (AD). ...
Hiroyuki Umegaki,Takahiko Kawamura,Naoko Kawano et al.
Hiroyuki Umegaki et al.
Background/aims: Although recent evidence has indicated that type 2 diabetes mellitus (T2DM) in the elderly is a risk factor for cognitive dysfunction or dementia, few studies have prospectively observed this potential co...